Publication | Open Access
A Clinical, Pathological, and Genetic Characterization of Methotrexate-associated Lymphoproliferative Disorders
119
Citations
21
References
2013
Year
Our data demonstrate that patients in the EBVMCU, a specific clinical subgroup of MTX-LPD, had a better clinical outcome when MTX was withdrawn than did other patients with MTX-LPD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1